{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:11:01Z","timestamp":1792001461594,"version":"4.4.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.juro.2010.06.147","type":"journal-article","created":{"date-parts":[[2010,9,18]],"date-time":"2010-09-18T08:27:19Z","timestamp":1284798439000},"page":"1915-1919","source":"Crossref","is-referenced-by-count":110,"title":["Bacillus Calmette-Gu\u00e9rin With or Without Interferon \u03b1-2b and Megadose Versus Recommended Daily Allowance Vitamins During Induction and Maintenance Intravesical Treatment of Nonmuscle Invasive Bladder Cancer"],"prefix":"10.1097","volume":"184","author":[{"given":"Kenneth G.","family":"Nepple","sequence":"first","affiliation":[{"name":"Department of Urology, University of Iowa, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Lightfoot","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Iowa, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry M.","family":"Rosevear","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Iowa, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"O'Donnell","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Iowa, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald L.","family":"Lamm","sequence":"additional","affiliation":[{"name":"BCG Oncology, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Bladder Cancer Genitourinary Oncology Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2010.06.147_bib1","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1289\/ehp.94102590","article-title":"Priorities for future IARC monographs on the evaluation of carcinogenic risks to humans","volume":"102","author":"Vainio","year":"1994","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.juro.2010.06.147_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.juro.2010.06.147_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urology.2005.07.062","article-title":"Bladder cancer: epidemiology, staging and grading, and diagnosis","volume":"66","author":"Kirkali","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.juro.2010.06.147_bib4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.eururo.2004.03.017","article-title":"Non-invasive urothelial neoplasms: according to the most recent WHO classification","volume":"46","author":"Lopez-Beltran","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2010.06.147_bib5","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1182\/blood-2005-03-1327","article-title":"Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL\/Apo-2L","volume":"106","author":"Kemp","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.juro.2010.06.147_bib6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.06.147_bib7","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJM199110243251703","article-title":"A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder","volume":"325","author":"Lamm","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2010.06.147_bib8","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.juro.2007.09.003","article-title":"Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update","volume":"178","author":"Hall","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.06.147_bib9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0022-5347(17)55150-2","article-title":"Treatment of residual, non-infiltrating bladder cancer with bacillus Calmette-Guerin","volume":"125","author":"Morales","year":"1981","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.06.147_bib10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.urology.2005.06.135","article-title":"High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder","volume":"66","author":"Sylvester","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.juro.2010.06.147_bib11","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.06.147_bib12","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.urology.2003.11.049","article-title":"Intravesical bacille Calmette-Guerin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression","volume":"63","author":"Bohle","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.juro.2010.06.147_bib13","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.06.147_bib14","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0022-5347(17)37452-9","article-title":"Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup","volume":"147","author":"Herr","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.06.147_bib15","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0022-5347(17)36197-9","article-title":"Intravesical bacillus Calmette-Guerin immunoprophylaxis of superficial bladder cancer: results of a controlled prospective trial with modified treatment schedule","volume":"149","author":"Melekos","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.06.147_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0022-5347(17)37707-8","article-title":"A low dose bacillus Calmette-Guerin regimen in superficial bladder cancer therapy: is it effective?","volume":"146","author":"Pagano","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.06.147_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00345-006-0112-0","article-title":"Treatment options for BCG failures","volume":"24","author":"O'Donnell","year":"2006","journal-title":"World J Urol"},{"key":"10.1016\/j.juro.2010.06.147_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0022-5347(17)34863-2","article-title":"Megadose vitamins in bladder cancer: a double-blind clinical trial","volume":"151","author":"Lamm","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.06.147_bib19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00005392-200101000-00074","article-title":"Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo","volume":"165","author":"Konety","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.06.147_bib20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1207\/s15327914nc5302_3","article-title":"Case-control analysis of dietary folate and risk of bladder cancer","volume":"53","author":"Schabath","year":"2005","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.juro.2010.06.147_bib21","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0022-5347(17)38622-6","article-title":"Internalization of bacille Calmette-Guerin by bladder tumor cells","volume":"145","author":"Becich","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.06.147_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00294021","article-title":"Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer","volume":"19","author":"de Boer","year":"1991","journal-title":"Urol Res"},{"key":"10.1016\/j.juro.2010.06.147_bib23","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.4049\/jimmunol.162.4.2399","article-title":"IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guerin immunotherapy","volume":"162","author":"Luo","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.juro.2010.06.147_bib24","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1084\/jem.189.9.1451","article-title":"Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs","volume":"189","author":"Kayagaki","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.juro.2010.06.147_bib25","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1084\/jem.190.8.1155","article-title":"Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)","volume":"190","author":"Fanger","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.juro.2010.06.147_bib26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF01517219","article-title":"Antiproliferative effects of bacillus Calmette-Guerin and interferon alpha 2b on human bladder cancer cells in vitro","volume":"41","author":"Pryor","year":"1995","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.juro.2010.06.147_bib27","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0022-5347(17)39547-2","article-title":"A randomized controlled study of intravesical alpha-2b-interferon in carcinoma in situ of the bladder","volume":"144","author":"Glashan","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.06.147_bib28","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/S0022-5347(01)63160-4","article-title":"Superficial bladder cancer: the role of interferon-alpha","volume":"159","author":"Belldegrun","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.06.147_bib29","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.urolonc.2005.11.026","article-title":"Final results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alpha-2B for reducing recurrence of superficial bladder cancer","volume":"24","author":"Joudi","year":"2006","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2010.06.147_bib30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000475068","article-title":"Adjuvant treatment with a vitamin A analogue (etretinate) after transurethral resection of superficial bladder tumors","volume":"28","author":"Studer","year":"1995","journal-title":"Eur Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534710040693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534710040693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2010.06.147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T15:43:46Z","timestamp":1711813426000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2010.06.147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.1016\/j.juro.2010.06.147"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2010.06.147","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}